 |
|
|
| |
C-EDGE: HEAD 2 HEAD - Efficacy and Safety of Elbasvir/Grazoprevir versus Sofosbuvir /Pegylated Interferon/Ribavirin (PR) in Treatment-Naïve and Prior PR Treatment Failure Subjects with Chronic HCV GT1 or 4 Infection
|
| |
| |
Reported by Jules Levin
EASL 2016 Barcelona April 14-17
Jan Sperl, Gabor Horvath, Waldemar Halota, Juan Arenas Ruiz-Tapiador, Anca Streinu-Cercel, Ligita Jancoriene, Klara Werling, Hege Kileng, Seyfettin Koklu, Jan Gerstoft, Sushma Patel, Jingjun Qiu, Ernest Assante-Appiah, Janice Wahl, Bach-Yen Nguyen, Eliav Barr, Heather L. Platt
|
| |
|
|
|
|
|
